- Home
- LENZ vs KFS Comparison
LENZ vs KFS Comparison
Compare LENZ & KFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LENZ | KFS |
|---|---|---|
| Founded | 2019 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 278.4M | 306.3M |
| IPO Year | 2021 | 2013 |
Fundamental Metrics
Financial Performance| Metric | LENZ | KFS |
|---|---|---|
| Price | $7.79 | $11.20 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $44.00 | N/A |
| AVG Volume (30 Days) | ★ 734.8K | 63.5K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $19,088,000.00 | ★ $134,996,000.00 |
| Revenue This Year | $50.42 | N/A |
| Revenue Next Year | $197.16 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 23.42 |
| 52 Week Low | $8.25 | $9.84 |
| 52 Week High | $50.19 | $16.80 |
Technical Indicators
Market Signals| Indicator | LENZ | KFS |
|---|---|---|
| Relative Strength Index (RSI) | 34.69 | 50.20 |
| Support Level | N/A | $10.00 |
| Resistance Level | $10.34 | $12.07 |
| Average True Range (ATR) | 0.64 | 0.55 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 28.21 | 56.61 |
Price Performance
Historical ComparisonAbout LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
About KFS Kingsway Financial Services Inc. (DE)
Kingsway Financial Services Inc through subsidiaries operates in the extended warranty and business services industries in the United States. The company operates through segments namely, Extended Warranty and Kingsway Search Xcelerator. The Extended Warranty segment provides after-market vehicle protection services distributed by credit unions. The company generates maximum revenue from the Extended Warranty segment in the form of Service fee and commission income.